SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Marina Biotech, Inc. Announces That Licensee ProNAi Therapeutics, Inc. Reported Phase 1 Study Results Using SMARTICLES® Nucleic Acid Delivery Technology